Kenneth A. Clark, age 67, has served on our Board of Directors since October 2021. Mr. Clark has been a partner of Wilson Sonsini Goodrich & Rosati P.C., a law firm, since April 1993, where he advises biotech companies on strategic partnerships, mergers and acquisitions, financing transactions and operational matters. He has also been a partner of TCG Labs, a venture capital fund affiliated with The Column Group, since October 2023. Mr. Clark previously served as Chief Business Officer at Alector, Inc. from October of 2022 through March of 2023. Mr. Clark has previously served as a member of the boards of directors for multiple publicly traded companies, including Pulse BioSciences, Inc. and Pharmacyclics, Inc, and is currently a director of Acurex Biosciences, a private company. Mr. Clark received his undergraduate degree from Vanderbilt University and a juris doctorate from the University of Texas School of Law. The Board of Directors has determined that Mr. Clark qualifies as an independent director under applicable Nasdaq rules. We believe Mr. Clark is qualified to serve on our Board of Directors because of his expertise in business consulting, deal transactions, financing, and corporate law in the biotechnology sector.